Drug metabolism
[SH4:p14]
=== Unfinished ===
Need to add stuffs about slow/fast acetylators
======
Role of metabolism
- .. to convert lipid-soluble drug into water-soluble metabolites
- By increasing water solubility
--> Decrease Vd, and enhance renal excretion and sometimes GIT elimination
- Metabolism does not always lead to pharmacologically inactive metabolite
* e.g. diazepam and propranolol may be metabolised into active compounds
Rate of metabolism
Rate of metabolism depends on
- Concentration of drug at the site of metabolism
- Intrinsic rate of metabolism process
First-order kinetics
- Amount of drug eliminated is proportional to the plasma concentration
* e.g. Most drugs
Zero-order kinetics
- Constant amount of drug is eliminated, regardless of plasma concentration
* Occurs when the plasma concentration exceeds enzyme capacity
* e.g. alcohol, aspirin, phenytoin
Pathways of metabolism
4 basic pathways
- Oxidation
* e.g. hydroxylation, deamination, desulfuration, dealkylation, dehalogenation
* Reactive intermediates may cause organ damage
- Reduction
* More common when oxygen partial pressure is low
- Hydrolysis
* Do not involve cytochrome P-450 enzymes
* Nonmicrosomal enzymes are involved
- Conjugation
* Conjugation with glucuronic acid involves cytochrome P-450 enzymes
* Decreased in neonates and during pregnancy
2 phases
- Phase I
* Oxidation, reduction, and hydrolysis
* Increase drug's polarity, preparing it for phase II
- Phase II
* Conjugation reactions
* Increase water solubility by linking with a highly polar molecule
Site of metabolism
- Liver
- Plasma (Hofmann elimination, ester hydrolysis)
- Lungs
- Kidneys
- GIT
* Especially small intestine
* Cytochrome P-450 enzymes
Enzymes involved
- Microsomal enzymes
* Mainly located in the hepatic smooth endoplasmic reticulum
* Can also be present in kidney, GIT, adrenal cortex
Phase I enzymes
[SH4:p15]
Enzymes involved in phase I reactions include:
- Cytochrome P-450 enzymes
- Non-cytochrome P-450 Enzymes (Esters)
- Flavin-containing monooxygenase enzymes
1. Cytochrome P-450 enzymes
aka mixed function oxidase system, or mono-oxygenases
- Superfamily of membrane-bound heme proteins
* Predominantly hepatic microsomal enzymes
* Some mitochondrial P-450 enzymes
- When combined with carbon monoxide
--> peak absorption at 450nm
- Involved in both oxidation and reduction
- Functions as the terminal oxidase in the electron transport scheme
Grouping of cytochrome P-450 enzymes
- Enzymes that share more than 40% of sequence homology
--> Grouped into a family
* e.g. CYP2
- Enzymes that share more than 55% of sequence homology
--> Grouped into a subfamily
* e.g. CYP2A
- Individual enzymes are then assigned an individual number
* e.g. CYP2A6
Actions of cytochrome P-450 enzymes
- 10 isoforms of cytochrome P-450 are responsible for the oxidative metabolism of most drugs
- Most CYP activities are generated by CYP2D6, CYP3A4, CYP3A5
CYP3A4
- Most abundant
- Comprising 20% to 60% of total P-450 activity
- CYP3A4 + CYP3A5
--> Responsible for metabolism of more than half of the currently available drugs
* e.g. opoids (alfentanil, sufentanil, fentanyl)
* e.g. benzodiazepines, local anaesthetics (lidocaine, ropivacaine)
* e.g. immunosuppresants (cyclosporine), antihistamines (terfenadine)
- Gender dependent
--> Clearance of some drugs are 20-40% higher in women
* Due to stimulation by steroid hormone
CYP2D6
- Responsible for 25% of drugs
- e.g. analgesics, antidysrhythmics, amide local anesthetics, ketamine, propofol, antiemetics, and betablocker
For example,
- Codeine is converted to morphine and morphine-6-glucuronide
* By CYP2D6-mediated O-demethylation
- Quinidine inhibits CYP2D6
--> Markedly diminishes effect of codeine
Cytochrome P-450 and neonates
- Hepatic microsomal enzyme activity is low in neonates
* especially premature infants
--> Interferes with conjugation
--> Hyperbilirubinaemia of the neonate and risk of bilirubin encephalopathy
Cytochrome P-450 and enzyme induction
- Hepatic microsomal enzyme activity can be stimulated by drugs/chemicals
- Also occurs (to limited extent) in lungs, kidney, and GIT
For example,
- Phenobarbital
- Polycyclic hydrocarbons (e.g. in cigarette smoke)
NB:
- May increase risk of halothane hepatotoxicity
2. Noncytochrome P-450 enzymes (esters)
aka nonmicrosomal enzymes
- Involved in conjugation, hydrolysis
* All conjugation reactions (except for conjugation of glucuronic acid)
- Also involved (to less extent) in oxidation and reduction
- Present mainly in liver, also plasma and GIT
- (Plasma cholinesterase and acetylating enzymes) Do NOT undergo enzyme induction
* Activity level determined genetically
For example,
- Hydrolysis of drugs containing ester bonds
* Includes succinylcholine, atracurium, mivacurium, esmolol, ester local anaesthetics
Atypical cholinesterase
- Genetic mutation
- Glycine is substituted for an aspartate in anionic binding site
--> Loss of electrostatic interaction
--> Less drug-substrate binding
--> Dramatically increased duration of action for drugs such as succinylcholine and mivacurium
3. Falvin-containing monooxygenase enzymes
- Nicotinamide-adenine dinucleotide (NAD)-dependent microsomal enzymes
- Oxidise nitrogen, sulfur, and phosphorus-containing compounds
For example,
- FMO3 catalyzes oxidation of tricyclic antidepressants and H2 antagonists
Phase II enzymes
[SH4:p15]
Enzymes involved in phase II reactions include:
- Glucuronosyltransferase
- Glutathione-S-transferase
- N-acetyl-transferase
- Sulfotransferase
Glucuronosyltransferase
Uridine diphosphate glucuronosyltransferase
- A family of hepatic microsomal enzymes
- Catalyses covalent addition of glucuronic acid to compounds
--> More water soluble
Intestine contains beta-glucuronidase
--> Hydrolyse glucuronides back to parent compound
--> Reabsorbed and transport to liver for reconjugation
* Enterohepatic recirculation
For example,
- Propofol
--> Glucuronidation in liver and kidney
- Opioids
--> Undergoes glucuronidation
* Morphine-3-glucuronide and morphine-6-glucuronide
- Midazolam
--> Glucuronidation product 1-hydroxymidazolam (active)
* Contribute to prolonged effect in renal insufficiency
Glutathione-S-transferase
- Primarily a defensive system for detoxification and oxidative stress
- GST-dependent activation is responsible for compound A nephrotoxicity in rats
* Absence of toxicity in human is probably a species difference
N-Acetyl-Transferase
- Catalyse N-acetylation
- Common phase II reaction for heterocyclic aromatic amines and arylamine hydrazine
- Responsible for inactivation of isoniazid and hydralazine
- Genetic polymorphism
--> Fast and slow acetylators